BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Inoue H, Kosuga T, Kubota T, Konishi H, Shiozaki A, Okamoto K, Fujiwara H, Otsuji E. Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer. World J Surg Oncol 2021;19:173. [PMID: 34118953 DOI: 10.1186/s12957-021-02286-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Dai M, Zhang Z. Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis. Front Oncol 2022;12:814727. [DOI: 10.3389/fonc.2022.814727] [Reference Citation Analysis]
2 Aoyama T, Nakazono M, Segami K, Nagasawa S, Kano K, Hara K, Maezawa Y, Hashimoto I, Suematsu H, Watanabe H, Komori K, Tamagawa H, Yukawa N, Rino Y, Ogata T, Oshima T. Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment. J Gastrointest Cancer 2021. [PMID: 34921671 DOI: 10.1007/s12029-021-00777-w] [Reference Citation Analysis]
3 Wu L, Feng Y, Wu Z, Xu H, Zhang C, Ning J, Wang R, Chen J, Xie M, Zhang Y, Bu L, Hao J, Ma T. Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis. World J Surg Oncol 2021;19:272. [PMID: 34507562 DOI: 10.1186/s12957-021-02390-4] [Reference Citation Analysis]
4 Mo H, Li P, Jiang S. A novel nomogram based on cardia invasion and chemotherapy to predict postoperative overall survival of gastric cancer patients. World J Surg Oncol 2021;19:256. [PMID: 34454511 DOI: 10.1186/s12957-021-02366-4] [Reference Citation Analysis]
5 Zhaojun X, Xiaobin C, Juan A, Jiaqi Y, Shuyun J, Tao L, Baojia C, Cheng W, Xiaoming M. Correlation analysis between preoperative systemic immune inflammation index and prognosis of patients after radical gastric cancer surgery: based on propensity score matching method. World J Surg Oncol 2022;20:1. [PMID: 34980151 DOI: 10.1186/s12957-021-02457-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Huo J, Guan G, Cai J, Wu L. Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer. World J Surg Oncol 2022;20:4. [PMID: 34983559 DOI: 10.1186/s12957-021-02485-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang X, Wang D, Sun T, Li W, Dang C. Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection. BMC Cancer 2022;22:684. [PMID: 35729545 DOI: 10.1186/s12885-022-09774-z] [Reference Citation Analysis]
8 Demircan NC, Atcı MM, Demir M, Işık S, Akagündüz B. Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy. Asia Pac J Clin Oncol 2022. [PMID: 35538045 DOI: 10.1111/ajco.13784] [Reference Citation Analysis]
9 Luo L, Huang B, Chen C, Wang Y, Su C, Peng G, Zeng C, Wu Y, Wang R, Huang K, Qiu Z. A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters. Front Oncol 2022;11:819047. [DOI: 10.3389/fonc.2021.819047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Valletti M, Eshmuminov D, Gnecco N, Gutschow CA, Schneider PM, Lehmann K. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology. World J Surg Oncol 2021;19:245. [PMID: 34404403 DOI: 10.1186/s12957-021-02351-x] [Reference Citation Analysis]